Current and emerging pharmacotherapies for hereditary hemorrhagic telangiectasia
Author:
Affiliation:
1. Centro de Investigaciones Biológicas, CSIC, Madrid, Spain
2. Medical Genetics Groug, U-707 CIBERer (Network of Biomedicine Investigation Centers on Rare diseases)
3. Department of Internal Medicine, Hospital de Sierrallana, Cantabria, Spain
Funder
Ministerio de 382 Economia y Competitividad
CIBERER
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Link
https://www.tandfonline.com/doi/pdf/10.1080/21678707.2017.1353417
Reference80 articles.
1. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)
2. Hereditary haemorrhagic telangiectasia: Pathophysiology, diagnosis and treatment
3. Pulmonary Arteriovenous Malformations
4. Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients
5. Cerebral arteriovenous malformations in the Netherlands Antilles
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care;Blood;2021-02-18
2. RiHHTa, un registro clínico español ejemplo de trabajo multicéntrico en red para una enfermedad rara;Revista Clínica Española;2018-12
3. RiHHTa, a Spanish clinical registry as an example of networked multicentre activities for a rare disease;Revista Clínica Española (English Edition);2018-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3